1. Home
  2. ALT vs HDSN Comparison

ALT vs HDSN Comparison

Compare ALT & HDSN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALT
  • HDSN
  • Stock Information
  • Founded
  • ALT 1997
  • HDSN 1991
  • Country
  • ALT United States
  • HDSN United States
  • Employees
  • ALT N/A
  • HDSN N/A
  • Industry
  • ALT Biotechnology: Pharmaceutical Preparations
  • HDSN Industrial Specialties
  • Sector
  • ALT Health Care
  • HDSN Consumer Discretionary
  • Exchange
  • ALT Nasdaq
  • HDSN Nasdaq
  • Market Cap
  • ALT 292.0M
  • HDSN 410.9M
  • IPO Year
  • ALT N/A
  • HDSN 1994
  • Fundamental
  • Price
  • ALT $3.83
  • HDSN $10.16
  • Analyst Decision
  • ALT Strong Buy
  • HDSN Buy
  • Analyst Count
  • ALT 6
  • HDSN 4
  • Target Price
  • ALT $17.40
  • HDSN $8.38
  • AVG Volume (30 Days)
  • ALT 3.0M
  • HDSN 429.8K
  • Earning Date
  • ALT 08-12-2025
  • HDSN 07-30-2025
  • Dividend Yield
  • ALT N/A
  • HDSN N/A
  • EPS Growth
  • ALT N/A
  • HDSN N/A
  • EPS
  • ALT N/A
  • HDSN 0.40
  • Revenue
  • ALT $20,000.00
  • HDSN $224,778,000.00
  • Revenue This Year
  • ALT N/A
  • HDSN $3.02
  • Revenue Next Year
  • ALT $761,880.20
  • HDSN $8.53
  • P/E Ratio
  • ALT N/A
  • HDSN $25.67
  • Revenue Growth
  • ALT N/A
  • HDSN N/A
  • 52 Week Low
  • ALT $2.90
  • HDSN $5.11
  • 52 Week High
  • ALT $11.16
  • HDSN $10.34
  • Technical
  • Relative Strength Index (RSI)
  • ALT 51.79
  • HDSN 68.01
  • Support Level
  • ALT $3.35
  • HDSN $9.32
  • Resistance Level
  • ALT $3.66
  • HDSN $10.34
  • Average True Range (ATR)
  • ALT 0.19
  • HDSN 0.24
  • MACD
  • ALT 0.07
  • HDSN 0.01
  • Stochastic Oscillator
  • ALT 86.18
  • HDSN 82.35

About ALT Altimmune Inc.

Altimmune Inc is a clinical-stage biopharmaceutical company focused on developing treatments for obesity, metabolic diseases, and liver diseases. Its product candidate, pemvidutide (formerly known as ALT-801), is a novel, investigational, peptide-based GLP-1/glucagon dual receptor agonist. Pemvidutide is currently in clinical development for obesity and metabolic-associated steatohepatitis (MASH). The company also plans to pursue additional indications for pemvidutide that leverage the differentiated clinical profile of pemvidutide.

About HDSN Hudson Technologies Inc.

Hudson Technologies Inc is an American industrial products manufacturer. It develops products which are mainly used in commercial air conditioning, industrial processing, and refrigeration systems. The company products include refrigerant and industrial gases, refrigerant management services and RefrigerantSide services, which consist of system decontamination. These are performed at customer's site using its Zugibeast system, which is a fast and portable system and allows the R-Side services team to accelerate critical services while saving customers time, money and aggravation. The company also owns a web-based real-time monitoring service which is used in the facility's refrigeration systems and other energy systems.

Share on Social Networks: